No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
299 |
4. Check minimum number of eventsNone |
299 |
5. Include endpointsNone |
299 |
6. Filter based on genotype QC (FinnGen only) |
299 |
Control definitions (FinnGen only)
- Control exclude
- N14_GLOMERULAR
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- N00-N08
- Name in latin
- Haematuria recidiva et persistens
Similar endpoints
↥List of similar endpoints to
Recurrent and persistent haematuria
based on the number of shared cases.
Similar with more cases:
- Glomerulonephritis
- Glomerular diseases
- Genitourinary diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2501 | 1150 | 1325 |
| Only index persons | 2128 | 1044 | 1084 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.03 | 0.04 |
| Only index persons | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 52.05 | 43.41 | 59.18 |
| Only index persons | 48.62 | 41.87 | 55.11 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 299 | 140 | 159 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 51.75 | 43.14 | 59.34 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 274
- Matched controls
- 2739
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N02.9
ICD-10 Finland
Recurrent and persistent haematuria, unspecified
+∞
152.8
132
*
R31
ICD-10 Finland
Unspecified haematuria
14.4
65.0
122
144
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
+∞
47.3
44
*
N02
ICD-10 Finland
Recurrent and persistent haematuria
+∞
31.9
30
*
UKC02
NOMESCO Finland
Cystoscopy
5.8
30.6
103
259
N02.0
ICD-10 Finland
Recurrent and persistent haematuria, minor glomerular abnormality
+∞
29.7
28
*
N02.8
ICD-10 Finland
Recurrent and persistent haematuria, other
+∞
29.7
28
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
29.9
24.2
32
12
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
+∞
22.2
21
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
87.4
22.0
24
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
29.3
21.8
29
11
A11CC03
ATC
alfacalcidol; systemic
23.9
21.3
30
14
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
+∞
21.1
20
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
18.9
21.1
32
19
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
52.4
20.5
24
5
N18.8
ICD-10 Finland
Other chronic renal failure
21.4
20.0
29
15
B03XA01
ATC
erythropoietin; parenteral
71.5
18.0
20
*
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
+∞
17.9
17
*
A12AA04
ATC
calcium carbonate; oral
45.3
17.5
21
5
N02.1
ICD-10 Finland
Recurrent and persistent haematuria, focal and segmental glomerular lesions
+∞
15.8
15
*
N02.2
ICD-10 Finland
Recurrent and persistent haematuria, diffuse membranous glomerulonephritis
+∞
15.8
15
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
6.9
15.7
40
66
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
7.7
15.3
36
53
Z94.0
ICD-10 Finland
Kidney transplant status
33.8
15.0
19
6
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
60.1
15.0
17
*
N02.3
ICD-10 Finland
Recurrent and persistent haematuria, diffuse mesangial proliferative glomerulonephritis
+∞
14.7
14
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
158.0
14.6
15
*
L04AA06
ATC
mycophenolic acid; systemic
20.5
14.5
21
11
137
Kela drug reimbursment
Uraemia requiring dialysis
79.2
13.7
15
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
22.5
12.2
17
8
R80
ICD-10 Finland
Isolated proteinuria
22.5
12.2
17
8
L04AD01
ATC
ciclosporin; systemic
21.1
11.3
16
8
B03XA02
ATC
darbepoetin alfa; parenteral
21.1
11.3
16
8
127
Kela drug reimbursment
Transplant complication
18.8
10.9
16
9
N18.0
ICD-10 Finland
End-stage renal disease
29.4
10.8
14
5
N02BE
ICD-10 Finland
NA
+∞
10.5
10
*
N02.4
ICD-10 Finland
Recurrent and persistent haematuria, diffuse endocapillary proliferative glomerulonephritis
+∞
10.5
10
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
10.4
52
174
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
41.7
10.0
12
*
B05DA
ATC
Isotonic solutions
57.0
9.7
11
*
B05DB
ATC
Hypertonic solutions
57.0
9.7
11
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
103.4
9.5
10
*
TK800
NOMESCO Finland
Hemodialysis
11.2
9.4
17
16
J01MA02
ATC
ciprofloxacin; systemic
2.3
9.4
124
729
Z49.2
ICD-10 Finland
Other dialysis
38.0
9.1
11
*
C03CA01
ATC
furosemide; systemic
2.4
9.0
94
490
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.2
8.8
49
176
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
51.7
8.7
10
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.8
8.7
28
63
205
Kela drug reimbursment
Chronic hypertension
2.4
8.6
86
436
V03AE01
ATC
polystyrene sulfonate; oral
20.8
8.5
12
6
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
+∞
8.4
8
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
34.4
8.1
10
*
L04AA01
ATC
[U] ciclosporin; systemic
13.6
8.0
13
10
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
7.4
88
482
C09AA02
ATC
enalapril; systemic
2.5
7.4
65
308
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.9
7.3
45
174
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
30.9
7.2
9
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
20.7
7.2
10
5
C08CA01
ATC
amlodipine; oral
2.1
7.1
102
604
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
8.6
6.9
14
17
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.2
6.9
25
64
UKB02
NOMESCO Finland
Retrograde ureteroscopy
17.2
6.8
10
6
R60.0
ICD-10 Finland
Localized oedema
3.1
6.7
35
122
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
6.5
77
417
R33
ICD-10 Finland
Retention of urine
3.3
6.5
32
107
K65.0
ICD-10 Finland
Acute peritonitis
14.8
6.4
10
7
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
6.4
116
748
R50.9
ICD-10 Finland
Fever, unspecified
2.5
6.4
50
222
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
6.4
102
627
N30.0
ICD-10 Finland
Acute cystitis
2.7
6.3
44
183
J01DB01
ATC
cefalexin; oral
2.1
6.3
221
1811
M05BA04
ATC
alendronic acid; oral
3.4
6.3
29
92
N03.2
ICD-10 Finland
Chronic nephritic syndrome, diffuse membranous glomerulonephritis
+∞
6.3
6
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
+∞
6.3
6
*
N04.2
ICD-10 Finland
Nephrotic syndrome, diffuse membranous glomerulonephritis
+∞
6.3
6
*
A02BC02
ATC
pantoprazole; systemic
1.9
6.2
170
1265
C09CA01
ATC
losartan; oral
2.2
6.0
67
353
N02BE01
ATC
paracetamol; systemic, rectal
2.1
6.0
224
1859
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3049717) Cytology report of Urine Cyto stain
46
93
5.66
22.41
3.2
2.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
176
913
3.26
22.21
11.4
4.4
g/l
34.4
35.7
2.08
168
861
(3017817) Protein [Mass] in Urine collected for unspecified duration
20
15
14.22
21.29
2.1
3.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
159
807
3.07
20.32
9.9
3.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
65
189
4.12
20.30
12.4
3.1
mmol/l
1.5
2.0
0.46
54
139
(3012544) pH of Venous blood
66
196
4.04
20.00
12.5
3.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
82
286
3.57
19.63
5.4
2.0
%
23.0
23.4
0.08
72
248
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
41
84
5.50
19.62
12.9
3.0
mmol/l
23.5
24.1
0.63
35
76
(3000850) Epithelial cells [#/volume] in Urine
112
475
3.17
19.48
8.1
2.4
e6/l
4.2
6.2
0.54
101
414
(3000991) Gas panel - Venous blood
60
171
4.14
19.20
13.7
6.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
130
606
3.03
19.08
9.4
3.7
mg/mmol
33.0
10.0
2.69
108
385
(3012516) Albumin [Mass/volume] in Urine
124
567
3.03
18.78
7.8
3.1
mg/l
616.3
169.8
0.56
103
369
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
20
19
11.21
18.41
1.1
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
182
1057
2.84
17.17
17.1
6.3
mmol/l
1.2
1.2
0.15
161
894
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
26
39
7.21
16.86
7.8
4.9
iu/ml
184.2
362.0
—
5
5
(3002582) Erythrocytes [#/volume] in Urine
135
687
2.76
16.25
9.9
3.1
e6/l
104.9
156.4
0.22
110
530
(3026782) Osmolality of Urine
103
455
2.93
16.23
7.2
2.6
mosm/kgh2o
554.8
558.4
0.06
93
381
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
169
967
2.72
16.06
14.3
5.6
mmol/l
1.2
1.2
0.09
157
873
(3009508) Creatinine [Moles/volume] in Urine
127
632
2.75
15.90
7.7
2.9
mmol/l
7.6
8.0
0.41
112
532
(3018095) Leukocytes [#/volume] in Urine
149
806
2.69
15.77
10.7
3.6
e6/l
74.3
66.0
0.09
118
573
(3026493) Urate [Moles/volume] in Serum or Plasma
118
579
2.71
15.03
3.9
2.6
umol/l
3308.4
7723.9
0.61
111
505
(3018418) pH of Serum or Plasma
127
652
2.65
14.71
12.1
3.5
ph
7.4
7.4
0.26
25
119
(3035350) Ketones [Presence] in Urine by Test strip
183
1129
2.60
14.32
7.9
3.4
estimate
0.0
0.0
0.00
33
220
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
21
30
7.45
14.17
5.4
4.6
—
5455.0
—
0
5
(3037467) Urinalysis macro (dipstick) panel - Urine
227
1562
2.88
14.13
10.1
4.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
185
1156
2.57
13.95
7.9
3.4
estimate
0.0
0.0
0.00
33
207
(3023368) Bacteria identified in Blood by Culture
120
614
2.59
13.82
7.3
4.6
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
13
0
+∞
13.64
1.3
0.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
26
49
5.72
13.50
1.8
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
132
718
2.50
13.24
5.5
3.1
mmol/l
2.3
2.3
1.87
120
630
(3021601) Nitrite [Presence] in Urine by Test strip
181
1137
2.50
13.23
10.6
4.7
estimate
0.0
0.0
0.50
33
221
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
26
50
5.60
13.21
2.0
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
118
618
2.50
12.74
8.8
3.0
e6/l
0.3
0.4
0.64
93
460
(3026008) Bacteria identified in Urine by Culture
118
633
2.43
11.95
4.5
2.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
25
51
5.26
11.91
1.4
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
115
612
2.43
11.83
8.1
2.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
22
40
5.86
11.83
1.8
3.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
213
1484
2.51
11.80
10.4
4.2
e6/l
183.3
275.5
—
10
27
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
104
532
2.46
11.64
2.4
2.0
mg/l
2.8
3.0
0.57
93
450
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
0
+∞
11.53
5.9
0.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
133
762
2.34
11.50
9.8
5.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
73
321
2.69
11.14
2.9
2.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
60
238
2.90
11.13
7.3
8.8
mmol/l
0.8
1.2
0.21
44
189
(3037121) Protein [Mass/volume] in Urine
27
63
4.61
11.01
3.6
4.0
g/l
0.7
0.1
0.90
12
25
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
26
60
4.65
10.74
1.8
3.2
—
1.3
—
0
8
(3048929) Epstein Barr virus Ab [Presence] in Serum
32
88
3.95
10.57
1.4
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
26
61
4.57
10.53
1.9
3.3
mg/l
47.2
149.1
0.51
18
51
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
26
61
4.57
10.53
1.9
3.3
mg/l
35.0
31.2
0.22
18
51
(3001122) Ferritin [Mass/volume] in Serum or Plasma
160
1018
2.23
10.47
4.7
2.5
ug/l
141.2
117.7
0.78
148
939
(3016502) Oxygen saturation in Arterial blood
54
211
2.90
10.25
7.3
9.4
%
94.7
95.7
0.56
48
202
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
31
6.11
10.19
2.1
2.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
28
6.38
10.04
1.1
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
41
138
3.28
10.03
4.2
3.1
ph
7.4
7.4
—
8
15
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
22
48
4.87
9.70
1.7
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
39
130
3.30
9.68
4.3
3.2
mmol/l
2.1
1.4
0.42
27
99
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
31
5.75
9.08
7.3
2.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
94
509
2.24
8.88
6.8
3.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
75
369
2.38
8.86
6.1
2.7
e6/l
1.9
1.0
0.67
47
207
(3027801) Oxygen [Partial pressure] in Arterial blood
55
236
2.63
8.68
8.0
8.8
kpa
11.3
12.1
0.52
50
227
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
55
236
2.63
8.68
7.9
8.8
kpa
4.9
5.0
0.28
50
225
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
140
891
2.07
8.66
8.3
3.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
173
1190
2.08
8.66
11.0
5.7
e9/l
2.3
1.9
0.43
157
1064
(3021901) Oxygen saturation in Capillary blood
19
41
4.88
8.47
2.7
2.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
139
889
2.05
8.42
3.3
2.1
nmol/l
70.2
74.9
1.48
133
791
(3032080) INR in Blood by Coagulation assay
135
857
2.05
8.33
10.1
8.4
inr
1.1
1.2
1.33
43
275
(3013115) Eosinophils [#/volume] in Blood
172
1194
2.04
8.24
11.7
6.1
e9/l
0.2
0.2
0.17
159
1064
(3044640) Blood type and Crossmatch panel - Blood
117
710
2.06
8.12
3.1
2.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
60
277
2.46
8.11
10.1
6.6
mmol/l
103.8
104.3
0.38
55
272
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
71
355
2.31
8.02
6.5
2.9
e6/l
1.9
2.4
0.24
42
197
(3001604) Monocytes [#/volume] in Blood
167
1155
2.01
8.00
11.2
5.7
e9/l
0.6
0.6
0.98
151
1011
(3006315) Basophils [#/volume] in Blood
167
1158
2.00
7.91
11.2
5.7
e9/l
0.0
0.0
0.43
152
1019
(3013650) Neutrophils [#/volume] in Blood by Automated count
185
1337
2.01
7.70
16.1
9.5
e9/l
4.4
4.1
0.98
173
1179
(3024928) Oxygen saturation in Venous blood
16
33
5.07
7.49
6.1
3.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
224
1747
2.13
7.38
13.4
7.1
u/l
76.4
76.8
0.04
217
1628
(21494890) Protein electrophoresis panel - 24 hour Urine
12
19
6.54
7.30
1.3
3.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
34
125
2.94
7.14
7.7
5.1
mmol/l
23.9
24.7
0.60
34
125
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
62
3.75
7.01
3.8
2.3
u/ml
0.3
0.3
0.27
12
35
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
30
105
3.06
6.86
10.1
13.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
62
314
2.23
6.72
1.3
1.3
titre
270.8
428.8
1.70
13
64
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
90
527
2.01
6.68
2.8
2.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
69
366
2.15
6.66
2.5
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
19
50
3.99
6.64
5.2
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
55
266
2.31
6.64
2.2
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
22
5.64
6.34
1.2
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
40
172
2.53
6.23
2.9
2.3
e9/l
69.7
68.3
0.11
31
129
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
52
254
2.27
6.12
2.5
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
85
502
1.97
6.09
8.4
3.6
kg/l
1.0
1.0
0.51
16
72
(3013826) Glucose [Moles/volume] in Serum or Plasma
177
1321
1.83
6.04
9.5
4.7
mmol/l
6.5
6.7
0.60
172
1224
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
36
150
2.59
5.98
1.9
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
69
385
2.03
5.77
2.0
1.6
nmol/l
1399.1
1201.7
0.71
54
288
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
38
168
2.45
5.58
3.6
2.6
ml/min/173m2
49.8
69.6
1.33
19
72
(3041096) Erythrocytes [Presence] in Urine by Automated
102
656
1.84
5.57
7.5
3.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
55
286
2.13
5.53
2.9
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
125
857
1.79
5.52
2.3
1.9
pmol/l
90.9
94.1
0.40
70
446
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
5
16.37
5.44
1.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
97
620
1.84
5.38
9.0
3.7
estimate
0.0
0.0
0.40
29
213
(3004588) Protein electrophoresis panel - Serum or Plasma
33
139
2.54
5.36
1.8
2.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
26
4.77
5.30
1.0
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
266
2314
2.35
5.30
33.3
13.6
mg/l
21.3
23.5
0.64
244
1819
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
156
1151
1.74
5.26
7.7
6.2
umol/l
12.9
11.3
0.39
156
1090
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
146
1059
1.74
5.22
5.9
4.1
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
5
0
+∞
5.22
1.6
0.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
34
148
2.46
5.16
4.9
2.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
84
519
1.86
5.16
1.7
1.5
nmol/l
16.5
20.8
2.77
79
444
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
6
13.65
5.10
1.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
27
106
2.70
5.04
6.6
3.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
49
253
2.12
5.01
2.5
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
57
3.30
4.85
1.3
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
30
131
2.43
4.53
6.9
7.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
98
662
1.71
4.36
2.7
2.2
u/l
133.8
348.8
1.21
93
636
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
181
2.19
4.32
1.7
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
43
224
2.07
4.29
5.3
3.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
73
2.86
4.28
1.6
2.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
64
388
1.83
4.10
6.6
3.3
ng/l
4167.4
206.2
0.48
47
292
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
109
768
1.66
4.10
4.1
2.9
u/l
29.7
32.9
0.46
104
728
(46235355) HIV 1 and 2 tests - Meaningful Use set
78
503
1.75
4.06
2.6
1.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
11
28
4.04
4.01
7.4
1.6
%
73.7
61.9
1.02
11
28
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
28
4.04
4.01
1.1
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
14
6.59
4.01
2.0
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
49
3.17
3.86
1.3
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
69
437
1.75
3.81
2.0
1.7
pmol/l
400.2
439.7
0.56
61
380
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
84
2.61
3.80
1.6
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
85
571
1.68
3.79
14.0
7.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
263
2350
1.99
3.74
39.0
15.2
mmol/l
4.0
4.0
3.01
258
2278
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
80
534
1.68
3.64
1.9
1.7
mg/l
0.8
1.3
1.75
62
413
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
64
402
1.75
3.63
2.7
1.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
262
2345
1.95
3.61
38.3
15.1
mmol/l
139.6
139.7
0.22
257
2274
(3052851) Hemolysis interference index of Serum or Plasma
16
57
2.91
3.58
5.0
3.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
63
2.80
3.55
1.8
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
13
6.29
3.52
4.4
2.0
%
11.9
10.9
—
8
13
(3045414) Leukocytes [Presence] in Urine
21
88
2.49
3.48
2.0
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
63
402
1.72
3.37
4.8
3.0
mmol/l
2.5
2.4
0.63
52
357
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
116
867
1.55
3.27
4.9
3.8
ng/l
48.7
45.1
0.10
86
599
(3022313) Gas panel - Capillary blood
23
104
2.31
3.25
4.2
3.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
27
132
2.15
3.18
1.3
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
20
4.60
3.14
2.1
2.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
204
1737
1.55
3.07
5.6
3.7
mm/h
15.6
11.2
2.66
194
1597
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
45
2.97
3.06
1.5
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
32
170
1.99
3.04
8.5
3.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
11
35
3.22
2.96
1.0
1.5
g/l
0.6
0.6
—
5
30
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
17
4.80
2.94
1.3
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
22
4.18
2.90
6.0
3.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
201
1720
1.51
2.84
4.0
3.8
pmol/l
14.6
14.7
0.22
183
1568
(3021589) Normoblasts [#/volume] in Blood
131
1036
1.47
2.70
18.8
9.4
e9/l
0.0
0.0
0.48
109
856
(3051651) Icteric interference index of Serum or Plasma
7
15
4.75
2.61
7.3
3.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
21
101
2.16
2.60
2.6
2.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
25
3.68
2.59
2.2
2.1
pg
32.1
33.2
—
9
25
(3014051) Protein [Presence] in Urine by Test strip
12
44
2.80
2.58
2.6
2.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
7
7.24
2.56
4.8
3.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
11
5.54
2.55
2.7
3.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
11
5.54
2.55
2.7
3.7
—
—
—
0
0
(3002256) Pathology report gross observation
46
291
1.69
2.53
1.3
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
44
275
1.70
2.53
29.4
24.3
inr
1.0
1.4
—
7
34
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
84
620
1.49
2.41
3.9
3.1
ng/l
3270.1
1402.9
0.93
73
523
(3013727) Leukocytes other/100 leukocytes in Blood
5
8
6.33
2.38
5.4
3.8
%
49.0
58.1
—
5
8
(3012441) Differential panel - Pleural fluid
7
18
3.95
2.26
2.3
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
9
5.63
2.22
4.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
9
5.63
2.22
1.0
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
9
5.63
2.22
1.0
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
12
49
2.51
2.13
1.8
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
25
3.26
2.11
1.6
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
20
3.56
2.06
1.0
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
32
194
1.73
2.06
11.8
3.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
26
3.13
2.03
1.4
2.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
112
902
1.39
1.95
2.2
2.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
22
3.23
1.89
1.0
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
46
2.44
1.87
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
46
2.44
1.87
2.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
46
2.44
1.87
2.7
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
10
40
2.55
1.85
1.2
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
28
169
1.72
1.85
4.6
5.2
%
0.0
0.2
—
9
51
(3012501) Base excess in Blood by calculation
12
53
2.32
1.83
6.0
2.1
mmol/l
2.4
2.4
—
5
35
(3013290) Carbon dioxide [Partial pressure] in Blood
12
53
2.32
1.83
6.0
2.1
kpa
4.9
5.0
0.29
12
53
(3027315) Oxygen [Partial pressure] in Blood
12
53
2.32
1.83
6.0
2.1
kpa
8.8
8.6
0.13
12
53
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
35
2.62
1.81
2.0
2.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
22
124
1.84
1.81
1.9
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
23
3.09
1.81
1.1
1.0
—
—
—
0
0
(3013512) EKG study
83
643
1.40
1.80
4.1
3.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
54
387
1.48
1.77
1.1
1.3
u/ml
18.0
9.1
0.21
19
158
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
18
3.38
1.75
1.7
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
241
2218
1.45
1.75
4.5
3.8
mmol/l
1.4
1.3
0.96
226
2036
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
251
2328
1.49
1.74
5.4
4.5
mmol/l
2.6
2.8
1.82
239
2147
(1761482) Bacteria [#/volume] in Urine by Culture
14
68
2.11
1.73
4.8
4.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
43
295
1.53
1.73
2.7
2.3
ug/g
126.8
142.5
0.13
33
231
(4062490)
6
19
3.20
1.67
1.0
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
49
2.29
1.65
2.0
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
20
3.04
1.59
1.0
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
85
1.93
1.58
1.4
2.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
64
2.08
1.56
1.8
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
67
513
1.39
1.55
1.2
1.3
u/ml
0.5
1.6
1.74
14
136
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
33
2.46
1.55
2.0
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
33
2.46
1.55
1.5
1.5
—
—
—
0
0
(4035726)
30
195
1.60
1.53
1.6
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
27
2.63
1.52
1.3
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
81
643
1.36
1.50
1.6
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
140
1.70
1.50
1.8
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
52
2.16
1.46
2.5
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
28
2.53
1.46
1.3
1.3
—
—
—
0
0
(3019225) pH of Specimen
30
198
1.57
1.44
9.0
3.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
27
174
1.61
1.43
3.7
4.7
%
1.1
0.4
—
7
44
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
238
2212
1.37
1.40
5.0
4.2
mmol/l
5.8
5.9
0.24
224
2033
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
245
2288
1.39
1.40
5.1
4.2
mmol/l
4.4
4.6
2.20
234
2122
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
41
2.23
1.38
1.9
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
244
2279
1.38
1.37
5.0
4.1
mmol/l
1.4
1.4
2.88
232
2104
(3044889) 12 lead EKG panel
177
1581
1.29
1.37
4.1
3.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
42
2.18
1.35
1.4
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
225
2080
1.33
1.32
7.2
5.3
mmol/mol
39.4
39.6
0.10
215
1945
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
53
401
1.39
1.32
1.2
1.3
iu/ml
81.0
35.1
0.37
13
125
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
59
455
1.37
1.31
1.6
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
24
2.53
1.31
1.2
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
235
2188
1.35
1.30
29.2
12.5
ml/min/173m2
71.3
84.0
8.29
195
1774
(3007164) IgA [Mass/volume] in Serum or Plasma
62
483
1.36
1.29
1.5
1.3
g/l
2.5
2.5
0.00
41
301
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
18
2.81
1.29
1.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
35
2.32
1.28
3.8
3.1
e9/l
3.9
4.5
—
8
35
(40760892) CBC W Ordered Manual Differential panel - Blood
69
548
1.34
1.27
7.1
4.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
36
2.26
1.25
3.9
3.2
%
59.9
59.2
—
8
36
(3045424) Erythrocytes [Presence] in Urine
8
37
2.19
1.22
1.1
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
37
2.19
1.22
1.5
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
71
1.87
1.21
4.0
2.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
64
1.91
1.19
1.9
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
38
2.13
1.19
1.0
1.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
38
2.13
1.19
1.3
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
26
2.33
1.19
1.5
1.8
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
26
2.33
1.19
2.3
1.3
%
92.5
89.2
—
6
26
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
174
1569
1.26
1.17
3.5
3.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
28
193
1.50
1.14
5.0
4.8
%
1.5
0.8
0.27
11
64
(3022145) Colonoscopy Study observation
35
253
1.43
1.13
1.7
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
39
288
1.41
1.12
3.0
2.7
umol/l
11.8
8.3
0.32
33
246
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
51
1.99
1.12
1.1
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
31
2.29
1.11
1.6
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
74
1.79
1.08
1.9
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
52
1.96
1.07
1.0
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
257
2448
1.35
1.03
29.7
12.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
83
1.72
1.03
3.1
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
15
91
1.68
1.02
1.1
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
223
2086
1.27
1.02
5.2
4.5
mu/l
1.8
1.9
0.71
208
1903
(3021440) Promyelocytes/100 leukocytes in Blood
26
181
1.48
1.02
5.2
5.0
%
0.4
0.2
0.32
11
59
(3000492) Spirometry study
33
242
1.41
1.00
1.3
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
23
2.19
0.98
1.0
1.2
nmol/l
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
23
2.19
0.98
2.4
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
229
2155
1.27
0.96
33.3
14.1
%
38.4
40.2
2.04
174
1641
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
27
2.25
0.94
1.2
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
52
1.75
0.93
1.8
1.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
6
28
2.17
0.92
1.0
1.2
nmol/l
—
—
—
0
0
(44790047)
6
29
2.09
0.90
1.0
1.4
—
—
—
0
0
(44790049)
6
29
2.09
0.90
1.0
1.4
—
—
—
0
0
(44806118)
6
29
2.09
0.90
1.0
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
29
2.09
0.90
1.5
1.8
—
—
—
0
0
(44790048)
6
29
2.09
0.90
1.0
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
29
2.09
0.90
4.8
3.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
45
1.80
0.85
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
45
1.80
0.85
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
69
582
1.24
0.81
1.8
1.6
mmol/l
1.4
1.4
0.01
61
490
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
98
1.56
0.80
1.9
1.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
25
2.02
0.73
1.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
25
2.02
0.73
3.0
3.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
40
1.77
0.71
1.9
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
19
135
1.44
0.71
3.3
3.5
pmol/l
4.5
4.6
0.17
19
118
(4268621)
5
26
1.94
0.71
2.0
2.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
34
267
1.31
0.71
2.0
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
95
839
1.19
0.71
5.4
5.0
ug/l
4.1
2.8
0.58
84
759
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
27
1.87
0.68
1.0
1.5
ug/l
28.4
16.5
—
5
27
(21494755) Public health laboratory ask at order entry panel
19
259
0.72
0.68
1.4
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
78
1.56
0.66
1.6
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
28
1.80
0.66
12.2
17.4
nmol/l
1838.0
1501.9
—
5
28
(40768797) Stomach Pathology biopsy report
36
288
1.28
0.66
1.1
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
12
79
1.54
0.63
1.6
2.4
g/l
0.1
0.8
1.40
12
73
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
51
1.58
0.61
1.1
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
80
1.52
0.60
2.8
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
21
0.00
0.60
0.0
3.4
—
71.6
—
0
21
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
36
1.68
0.57
1.3
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
171
0.69
0.56
1.2
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
260
1.26
0.54
1.6
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
146
0.67
0.53
1.4
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
63
1.44
0.53
1.0
1.4
—
—
—
0
0
(3020891) Body temperature
12
83
1.46
0.52
8.5
4.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
170
1603
1.14
0.51
4.2
2.9
u/l
43.7
45.9
0.21
162
1513
(3001019) Free T4 and TSH panel - Serum or Plasma
18
136
1.34
0.50
1.9
1.8
—
—
—
0
0
(4010399)
20
154
1.32
0.50
1.4
1.3
—
—
—
0
0
(4034850)
12
85
1.43
0.47
28.2
9.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
48
1.47
0.47
1.7
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
78
1.43
0.43
1.4
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
56
1.44
0.43
1.5
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
15
114
1.33
0.41
1.0
1.1
—
6.2
—
0
5
(3016244) Insulin [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.7
—
21.2
—
0
15
(3014271) Vancomycin [Susceptibility]
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
79
1.41
0.41
1.4
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
80
1.39
0.39
1.4
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
66
1.37
0.38
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
75
685
1.13
0.36
5.4
4.3
%
23.7
21.3
0.60
42
315
(3019832) Treponema pallidum Ab [Presence] in Serum
32
274
1.19
0.35
2.2
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
177
0.78
0.34
1.4
1.9
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
19
156
1.23
0.32
1.2
1.3
—
32.6
—
0
11
(3011288) Drugs identified in Urine by Screen method
8
66
1.22
0.27
3.0
1.9
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
38
1.32
0.23
1.8
2.3
umol/l
2.7
5.0
—
5
27
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
20
172
1.17
0.22
2.0
2.4
—
12.5
—
0
9
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
33
296
1.13
0.22
1.8
2.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
41
1.22
0.22
1.2
1.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.6
—
63.6
—
0
11
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
8.8
—
0
10
(3037556) Urate [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.7
—
52.4
—
0
12
(1761868) Lipid panel - Serum or Plasma
85
897
0.93
0.21
3.7
2.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
25
221
1.14
0.21
2.8
4.1
ug/l
3.4
9.9
1.78
20
181
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
3.9
—
0
5
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
473.3
—
0
8
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
36.8
—
0
8
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
264.6
—
0
8
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
217.7
—
0
14
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
23
258
0.88
0.18
25.8
7.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
59
1.19
0.18
1.9
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
61
1.15
0.17
1.7
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
61
1.15
0.17
1.7
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
70
0.71
0.17
1.8
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
69
1.16
0.16
1.7
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
84
1.20
0.14
2.9
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
35
325
1.09
0.14
1.8
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
105
1.15
0.11
2.7
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
28
262
1.08
0.09
4.2
4.1
%
33.7
31.1
0.70
23
164
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
48
1.04
0.09
1.2
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
34
359
0.94
0.09
1.6
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
19
175
1.09
0.08
1.3
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
107
1.13
0.08
2.7
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
107
1.13
0.08
2.7
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
107
1.13
0.08
2.7
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
57
1.05
0.08
1.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
113
0.88
0.08
1.3
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
53
510
1.05
0.08
3.6
3.1
ug/l
1.6
0.8
0.47
39
338
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
65
1.08
0.08
1.7
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
74
1.08
0.07
1.8
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
74
1.08
0.07
1.8
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
74
1.08
0.07
1.8
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
74
1.08
0.07
1.8
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
78
1.03
0.07
1.9
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
87
1.04
0.07
1.1
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
128
1.10
0.07
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
18
170
1.06
0.04
1.2
1.2
iu/ml
177.2
148.8
—
10
66
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
24
250
0.96
0.03
1.4
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
102
1.08
0.03
2.7
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
113
1.06
0.02
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
131
0.99
0.00
1.7
1.5
—
—
—
0
0
(1002224) Polysomnography panel
11
113
0.97
0.00
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
137
1.02
0.00
1.3
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
26
263
0.99
0.00
2.1
1.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
76
0.92
0.00
1.7
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
6
64
0.94
0.00
1.5
1.7
pmol/l
196.7
225.4
—
6
58
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(4094501)
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
5.8
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
7
0.00
0.00
0.0
2.4
—
10405.6
—
0
7
(3011897) Casein IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
2.0
—
0
5
(40765089) Chromosome analysis panel - Blood by G-banded
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
1.1
—
0
5
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint N14_RECURANDPERHEAMATUR and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| N14_RECURANDPERHEAMATUR | 2.32 [1.83, 2.94] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.11 |
During the follow-up period (1.1.1998 — 31.12.2019), 187 out of 1005 females with N14_RECURANDPERHEAMATUR died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| N14_RECURANDPERHEAMATUR | 2.256 [1.73, 2.94] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 422 out of 1118 males with N14_RECURANDPERHEAMATUR died.
Mortality risk
Mortality risk for people of age
years, who have N14_RECURANDPERHEAMATUR.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.215% | 0.347% |
| 5 | 1.295% | 2.358% |
| 10 | 3.217% | 5.811% |
| 15 | 5.868% | 11.113% |
| 20 | 10.82% | 18.533% |
Relationships between endpoints
↥Index endpoint: N14_RECURANDPERHEAMATUR – Recurrent and persistent haematuria
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data